Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2

Código QR

Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2

Abstract As SARS-CoV-2 vaccines are deployed worldwide, a comparative evaluation is important to underpin decision-making. We here report a systematic literature review and meta-analysis of Phase I/II/III human trials and non-human primates (NHP) studies, comparing reactogenicity, immunogenicity and...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ian McDonald, Sam M. Murray, Catherine J. Reynolds, Daniel M. Altmann, Rosemary J. Boyton
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Immunologic diseases. Allergy RC581-607 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/5f7d4b1caeb145c2af24bb7f27b2e13e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Reactogenicity and Immunogenicity of the Pfizer and AstraZeneca COVID-19 Vaccines
por: Waleed H. Mahallawi, et al.
Publicado: (2021)

Can reactogenicity predict immunogenicity after COVID-19 vaccination?
por: Young Hoon Hwang, et al.
Publicado: (2021)

THE EVALUATION OF REACTOGENICITY, SAFETY AND IMMUNOGENICITY OF THE POLYSACCHARIDE PNEUMOCOCCAL VACCINE DURING THE IMMUNIZATION OF HEALTH CARE WORKERS
por: I. V. Feldblum, et al.
Publicado: (2014)

Contributions of lipopolysaccharide and the type IVB secretion system to Coxiella burnetii vaccine efficacy and reactogenicity
por: Carrie M. Long, et al.
Publicado: (2021)

REACTOGENITY OF TICK-BORNE ENCEPHALITIS VACCINE ENCEPUR ADULT AND IMMUNE RESPONSE
por: G. N. Leonova, et al.
Publicado: (2014)

Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques
por: Pragya D. Yadav, et al.
Publicado: (2021)

Immunogenicity and reactogenicity of 2009 influenza A (H1N1) inactivated monovalent non-adjuvanted vaccine in elderly and immunocompromised patients.
por: João L Miraglia, et al.
Publicado: (2011)

Safety and reactogenicity of the adjuvanted recombinant zoster vaccine: experience from clinical trials and post-marketing surveillance
por: Joseph Fiore, et al.
Publicado: (2021)

A single blind, placebo-controlled randomized study of the safety, reactogenicity and immunogenicity of the “EpiVacCorona” Vaccine for the prevention of COVID-19, in volunteers aged 18–60 years (phase I–II)
por: A. B. Ryzhikov, et al.
Publicado: (2021)

Immunogenic and efficacious SARS-CoV-2 vaccine based on resistin-trimerized spike antigen SmT1 and SLA archaeosome adjuvant
por: Bassel Akache, et al.
Publicado: (2021)

Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models
por: Kirill V. Kalnin, et al.
Publicado: (2021)

A method to estimate probability of disease and vaccine efficacy from clinical trial immunogenicity data
por: Julie Dudášová, et al.
Publicado: (2021)

Protective efficacy of a SARS-CoV-2 DNA vaccine in wild-type and immunosuppressed Syrian hamsters
por: Rebecca L. Brocato, et al.
Publicado: (2021)

Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapy.
por: Vincenzo Mazzaferro, et al.
Publicado: (2021)

The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity
por: Carlos del Fresno, et al.
Publicado: (2021)

The effect of calcium and magnesium on activity, immunogenicity, and efficacy of a recombinant N1/N2 neuraminidase vaccine
por: Luca T. Giurgea, et al.
Publicado: (2021)

An Engineered Receptor-Binding Domain Improves the Immunogenicity of Multivalent SARS-CoV-2 Vaccines
por: Yan Guo, et al.
Publicado: (2021)

Efficacy (and safety) of vaccination against SARS-CoV-2 in cancer patients on active treatment
por: Tina Zupančič, et al.
Publicado: (2021)

SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice
por: Jing-Hui Tian, et al.
Publicado: (2021)

Co-Occurrence of SARS-CoV-2 Infection and Inactivated SARS-CoV-2 Vaccination among Healthcare Workers
por: Cucunawangsih Cucunawangsih, et al.
Publicado: (2021)

Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaques
por: Hyon-Xhi Tan, et al.
Publicado: (2021)

Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic
por: Samir Andrade Mendonça, et al.
Publicado: (2021)

Multiparameter telemetry as a sensitive screening method to detect vaccine reactogenicity in mice.
por: Margarete Arras, et al.
Publicado: (2012)

Artificial intelligence predicts the immunogenic landscape of SARS-CoV-2 leading to universal blueprints for vaccine designs
por: Brandon Malone, et al.
Publicado: (2020)

Strong immunogenicity of heterologous prime-boost immunizations with the experimental vaccine GRAd-COV2 and BNT162b2 or ChAdOx1-nCOV19
por: Chiara Agrati, et al.
Publicado: (2021)

IMMUNE THROMBOCYTOPENIA PURPURA FLARE POST SARS-COV-2 VACCINATION
por: Elrazi Ali, et al.
Publicado: (2021)

A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concern
por: Mitch Brinkkemper, et al.
Publicado: (2021)

Exploratory analysis of the effect of helminth infection on the immunogenicity and efficacy of the asexual blood-stage malaria vaccine candidate GMZ2.
por: Odilon Nouatin, et al.
Publicado: (2021)

Reply to: Before attributing encephalomyelitis to SARS‐CoV‐2 vaccinations exclude differentials
por: Karolina Kania, et al.
Publicado: (2021)

Before attributing encephalomyelitis to SARS‐CoV‐2 vaccinations thoroughly exclude differentials
por: Josef Finsterer
Publicado: (2021)

Human endogenous retrovirus-enveloped baculoviral DNA vaccines against MERS-CoV and SARS-CoV2
por: Hansam Cho, et al.
Publicado: (2021)

Safety and preliminary efficacy of the Gam-COVID-Vac vaccine and outcomes of SARS-CoV-2 infection in Russian patients with genitourinary malignancies
por: Ilya Tsimafeyeu, et al.
Publicado: (2021)

IMMUNOGENICITY OF ADJUVANT INFLUENZA VACCINE FOR PREGNANT WOMEN
por: M. P. Kostinov, et al.
Publicado: (2017)

SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates
por: Nikolaos C. Kyriakidis, et al.
Publicado: (2021)

Immunogenicity and protective efficacy of prime-boost immunization in mice vaccinated with live and inactivated influenza A (H5N1) vaccines
por: I. Losev, et al.
Publicado: (2019)

Efficacy of Serotherapy on an N501Y Variant of SARS-CoV-2 in a Patient With Chronic Lymphocytic Leukemia
por: Colin Vercueil, et al.
Publicado: (2021)

Protections against the Risk of Airborne SARS-CoV-2 Infection
por: Clement J. McDonald
Publicado: (2020)

Viral vector-based vaccines against SARS-CoV-2
por: Kenneth Lundstrom
Publicado: (2021)

Mucosal vaccination induces protection against SARS-CoV-2 in the absence of detectable neutralizing antibodies
por: Chaojie Zhong, et al.
Publicado: (2021)

Efficacy of intraoral antiseptics in SARS-CoV-2 infection control in dental clinics
por: Francisca Aline da Silva Matias, et al.
Publicado: (2021)